Skip to content
← Back to search
Award NoticeAwarded

Bupropion HCL ER

DEPT OF DEFENSE · DLA TROOP SUPPORT

This notice records an award. Find active opportunities

Award Information

This solicitation resulted in an award to RADHA PHARMACEUTICALS INC for approximately $23,278,524 on October 6, 2022. Similar contracts are typically issued by DEPT OF DEFENSE under 325412 (Pharmaceutical Preparation Manufacturing).

Award Number
SPE2D2-23-D-0002
Award Amount
$23,278,524
Award Date
October 6, 2022
Awardee
RADHA PHARMACEUTICALS INC

Contract Details

Solicitation number
SPE2D2-23-D-0002
Notice ID
SPE2D2-23-D-0002
Opportunity Type
Award Notice
Sub-Agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Posted Date
Monday, September 14, 2026
Response Deadline
Not specified
PSC Code
6505
Set-Aside
Full & Open Competition
Place of Performance
Hauppauge, NY, 11788, USA
Status
Awarded

Description

Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER

Documents and contact

Check the official notice for attachments and access requirements ↗

Contact
Kyle Lewicki
Email
kyle.lewicki@dla.mil
Phone
4457370977
Loadingchange history…
Loadingrelated notices…